Booth Bruce

DirectorKymera Therapeutics, Inc. (KYMR) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.4M
Net Open-Market Flow
-$3.4M
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Sell(S)11K$108.28$1.2M2.4M
Jun 29, 2026Sell(S)8K$109.75$860K2.4M
Jun 29, 2026Sell(S)8K$110.67$841K2.4M
Jun 29, 2026Sell(S)907$111.20$101K2.4M
Jun 29, 2026Sell(S)2K$108.28$183K464K
Jun 29, 2026Sell(S)1K$109.75$136K463K
Jun 29, 2026Sell(S)1K$110.67$133K462K
Jun 29, 2026Sell(S)157$111.20$17K462K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001451612-26-000020) within minutes of acceptance. Every field above traces to the original document. Verify it directly: